GE HealthCare Technologies Inc. (GEHC) Stock Analysis
Recovery setup
Healthcare · Medical Devices
Sell if holding. Multiple concerning factors at $66.12: Consecutive earnings misses (2); Concentration risk — Geographic: non-U.S. revenue.
GE HealthCare is a global medical technology company offering imaging, ultrasound, patient care solutions, and pharmaceutical diagnostics to hospitals, clinics, and life science customers in 160+ countries. It earns revenue through equipment sales, services, and recurring... Read more
Sell if holding. Multiple concerning factors at $66.12: Consecutive earnings misses (2); Concentration risk — Geographic: non-U.S. revenue. Chart setup: Death cross but MACD improving, RSI 54. Score 5.3/10, moderate confidence.
Passes 7/9 gates (positive momentum, favorable risk/reward ratio, clean insider activity, news events none recent, earnings proximity 45d clear, semi cycle peak clear, materials cycle peak clear). Suitability: moderate.
Recent developments
updated 2026-06-14Recent Developments — GE HealthCare Technologies Inc.
Latest news
- NEWS GE HealthCare Technologies Inc. stock falls Wednesday, underperforms market - MarketWatch — MarketWatch negative
- NEWS GE HealthCare Stock Sinks After Earnings. It’s Lagging Behind the Other Two GEs. - Barron's — Barron's negative
- NEWS GE HealthCare Technologies Stock (GEHC) Opinions on Q1 Earnings Miss and Guidance Cut - Quiver Quantitative — Quiver Quantitative negative
- NEWS Stocks making the biggest moves midday: GE HealthCare Technologies, Bloom Energy, Seagate, Teradyne, & more - CNBC — CNBC neutral
- NEWS GE HealthCare stock falls on guidance cut (GEHC:NASDAQ) - Seeking Alpha — Seeking Alpha negative
Generated 2026-06-15T18:11:46Z.
Upcoming dated catalysts
Thesis
Key Metrics
Quality Signals
Options Flow
Concentration Risks(10-K Item 1A)
- HIGHGeographicnon-U.S. revenue10-K Item 1A: 'We generate the majority of our revenue outside of the U.S.'
Material Events(8-K, last 90d)
- 2026-03-17Item 5.02LOWGE HealthCare appointed Monish Lobo to its Board of Directors, effective March 17, 2026.SEC filing →
- 2026-02-26Item 1.02MEDIUMGE HealthCare terminated its 2025 364-Day Revolving Credit Agreement, which was replaced by a new 2026 364-Day Revolving Credit Agreement providing a $1.0B revolving credit facility maturing February 25, 2027.SEC filing →
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.
Show full disclosure ▾Hide full disclosure ▴
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
Rating Breakdown
2 floor-breakers
Growth below the gate floor. Component breakdown shows what dragged the score down.static
Technicals below the gate floor. Component breakdown shows what dragged the score down.static
Price Targets
Position Sizing
Analyst Consensus
Earnings
Verdict History
Frequently Asked Questions
Sell if holding. Multiple concerning factors at $66.12: Consecutive earnings misses (2); Concentration risk — Geographic: non-U.S. revenue. Chart setup: Death cross but MACD improving, RSI 54. Prior stop was $61.82. Score 5.3/10, moderate confidence.
Take-profit target: $71.75 (+10.1% upside). Prior stop was $61.82. Stop-loss: $61.82.
Concentration risk — Geographic: non-U.S. revenue; Consecutive earnings misses (2); Weak growth.
GE HealthCare Technologies Inc. trades at a P/E of 15.6 (forward 12.2). TrendMatrix value score: 6.9/10. Verdict: Sell.
27 analysts cover GEHC with a consensus score of 4.0/5. Average price target: $80.
What does GE HealthCare Technologies Inc. do?GE HealthCare is a global medical technology company offering imaging, ultrasound, patient care solutions, and...
GE HealthCare is a global medical technology company offering imaging, ultrasound, patient care solutions, and pharmaceutical diagnostics to hospitals, clinics, and life science customers in 160+ countries. It earns revenue through equipment sales, services, and recurring consumable and software contracts with a focus on AI-enabled precision care.